NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES (Q2041388): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Label in wikidata changed)
(‎Created claim: summary (P836): THE IPLIGHT PROJECT FOCUSED ON THE TECHNOLOGICAL DEVELOPMENT OF IPSC MODELS APPLICABLE TO PHARMACEUTICAL RESEARCH IN CHRONIC DEGENERATIVE DISEASES AND ON THE VALIDATION AND APPLICATION OF THESE MODELS IN COMBINATION WITH HIGH-CONTENT AND HIGH-THROUGHPUT SCREENING METHODS USED TO IDENTIFY POTENTIAL MEDICINES. THE PRIMARY FOCUS ON PARKINSON’S DISEASE (PD), A RAPID ECR DISEASE, Adding English summary)
Property / summary
 
THE IPLIGHT PROJECT FOCUSED ON THE TECHNOLOGICAL DEVELOPMENT OF IPSC MODELS APPLICABLE TO PHARMACEUTICAL RESEARCH IN CHRONIC DEGENERATIVE DISEASES AND ON THE VALIDATION AND APPLICATION OF THESE MODELS IN COMBINATION WITH HIGH-CONTENT AND HIGH-THROUGHPUT SCREENING METHODS USED TO IDENTIFY POTENTIAL MEDICINES. THE PRIMARY FOCUS ON PARKINSON’S DISEASE (PD), A RAPID ECR DISEASE (English)
Property / summary: THE IPLIGHT PROJECT FOCUSED ON THE TECHNOLOGICAL DEVELOPMENT OF IPSC MODELS APPLICABLE TO PHARMACEUTICAL RESEARCH IN CHRONIC DEGENERATIVE DISEASES AND ON THE VALIDATION AND APPLICATION OF THESE MODELS IN COMBINATION WITH HIGH-CONTENT AND HIGH-THROUGHPUT SCREENING METHODS USED TO IDENTIFY POTENTIAL MEDICINES. THE PRIMARY FOCUS ON PARKINSON’S DISEASE (PD), A RAPID ECR DISEASE (English) / rank
 
Normal rank

Revision as of 09:38, 23 March 2020

Project in Italy financed by DG Regio
Language Label Description Also known as
English
NEW BIOTECHNOLOGICAL SYSTEMS IPSC FOR PHARMACEUTICAL DEVELOPMENT IN THE AREA OF NEURODEGENERATIVE DISEASES
Project in Italy financed by DG Regio

    Statements

    0 references
    1,379,705.73 Euro
    0 references
    2,759,411.46 Euro
    0 references
    50.0 percent
    0 references
    27 September 2016
    0 references
    29 November 2019
    0 references
    BIOREP S.R.L.
    0 references
    AXXAM SPA
    0 references
    CNR - CONSIGLIO NAZIONALE DELLE RICERCHE
    0 references
    UNIVERSITA' VITA-SALUTE SAN RAFFAELE
    0 references
    I.M.S. - ISTITUTO DI MANAGEMENT SANITARIO S.R.L.
    0 references
    0 references
    0 references
    0 references

    45°32'12.05"N, 9°11'15.83"E
    0 references
    IL PROGETTO IPSLIGHT FOCALIZZATO SULLO SVILUPPO TECNOLOGICO DI MODELLI IPSC (INDUCED PLURIPOTENT STEM CELL) APPLICABILI ALLA RICERCA FARMACEUTICA NELLAMBITO DELLE PATOLOGIE DEGENERATIVE CRONICHE E SULLA VALIDAZIONE E APPLICAZIONE DI TALI MODELLI IN COMBINAZIONE CON METODICHE ALLAVANGUARDIA DI HIGH-CONTENT E HIGH-THROUGHPUT SCREENING UTILIZZATE PER LIDENTIFICAZIONE DI POTENZIALI FARMACI. IL FOCUS PRIMARIO SULLA PATOLOGIA DI PARKINSON (PD - PARKINSONS DISEASE), UNA MALATTIA IN RAPIDA CRE (Italian)
    0 references
    THE IPLIGHT PROJECT FOCUSED ON THE TECHNOLOGICAL DEVELOPMENT OF IPSC MODELS APPLICABLE TO PHARMACEUTICAL RESEARCH IN CHRONIC DEGENERATIVE DISEASES AND ON THE VALIDATION AND APPLICATION OF THESE MODELS IN COMBINATION WITH HIGH-CONTENT AND HIGH-THROUGHPUT SCREENING METHODS USED TO IDENTIFY POTENTIAL MEDICINES. THE PRIMARY FOCUS ON PARKINSON’S DISEASE (PD), A RAPID ECR DISEASE (English)
    0 references

    Identifiers

    E76D17000120009
    0 references